November 15, 2017
Cardinal Health sells it’s China business to Shanghai Pharmaceuticals for $1.2B
Cardinal Health will sell its Cardinal Health China business to Shanghai Pharmaceuticals Holding for $1.2 billion.
Pharmaceuticals, Biotechnology and Life Sciences
Category: news
November 14, 2017
Hikma buys 6 Boehringer’s products
Hikma Pharmaceuticals has acquired six products from Boehringer Ingelheim GmbH (Boehringer Ingelheim).
November 14, 2017
Novartis to present new data about broad range of breast cancer
Novartis announced it would present data across its breast cancer portfolio and pipeline in a broad range of patient populations,…
November 14, 2017
Beximco increases comprehensive net income in Q1 2017, ships second product to US
Beximco Pharmaceuticals last week started the export of Sotalol Hydrochloride, a generic version of the cardiovascular drug Betapace, to the US.
November 14, 2017
Pertinax Pharma appoints ex Sanofi man as new chairman to deal with newly launched Pertinax
Pertinax Pharma has appointed Nigel Brooksby as chairman of the company. His main task will be the commercialisation of Pertinax,…
November 10, 2017
Eli Lilly’s Forteo reduces risk for new fractures in postmenopausal women with severe osteoporosis
Eli Lilly has reported new data showing that treatment with FORTEO for 24 months was associated with significantly fewer vertebral and clinical…
November 10, 2017
Sanofi develops Principa’s drug for multiple sclerosis
Sanofi will develop Principia Biopharma`s experimental oral treatment that could tackle multiple sclerosis (MS) and, maybe other central nervous system…
November 9, 2017
BN kicks off phase 2 study of RS virus vaccine, plans on human study next year
Bavarian Nordic has started the Phase 2 extension study of MVA-BN RSV, a universal vaccine candidate designed to elicit a broad…
November 8, 2017
Positive results from Novartis’s third phase testing of Kisqali in breast cancer
Novartis on Wednesday announced positive topline results from the global MONALEESA-7 trial, the second Phase III trial of Kisqali in…
November 7, 2017
Diplomat to acquire Pharmaceutical Technologies
Diplomat Pharmacy, has entered into a definitive agreement to acquire Pharmaceutical Technologies, doing business as National Pharmaceutical Services. The transaction…